Mental Health and Suicidality in Glioblastoma Patients in Germany

Recruiting now

Conditions studied: Glioblastoma (GBM)

In brief

The aim of the study is to use standardized questionnaires to systematically record influencing factors or predictors for suicidal behavior in glioblastoma patients, particularly with regard to existing depression and anxiety symptoms.

Key facts

Study ID

NCT07409584

Run by

University Hospital, Essen

People needed

176

Starts

2026-03-18

Expected to finish

2027-12-01

Last updated by the study team

2026-05-18

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of glioblastoma, IDH wild-type (CNS WHO classification of 2021)
• Age ≥ 18 years

You may not qualify if…

• Participants with clinically significant aphasia or language barrier as assessed by the investigator
• History of other malignant tumors
• Known tumor predisposition syndrome (e.g., Li-Fraumeni syndrome, Cowden syndrome, etc.)

Where it is running

• Charite — Berlin, Germany (enrolling)
• University Hospital Essen — Essen, Germany (enrolling)
• University hospital Hamburg Eppendorf — Hamburg, Germany (enrolling)
• University hospital Heidelberg — Heidelberg, Germany (enrolling)
• University hospital Muenster — Münster, Germany (enrolling)
• University Hospital Knappschaftskrankenhaus Bochum — Bochum, Germany

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.